Word

C

Status

Registered

Status Code

700

Status Date

Tuesday, August 2, 2022

Serial Number

79322618

Registration Number

6805688

Registration Date

Tuesday, August 2, 2022

Mark Type

3000

Filing Date

Friday, April 2, 2021

Published for Opposition

Tuesday, May 17, 2022

Trademark Owner History

CHIESI FARMACEUTICI S.P.A. - Original Registrant

Classifications

5 Pharmaceuticals for the treatment of diseases of the respiratory system, central nervous system [CNS], the metabolic system, the cardio-vascular system, the musculo-skeletal system, immune system, gastro-intestinal system, endocrine system, or caused by bacteria; Pharmaceuticals for the treatment of autoimmune disorders, viral diseases, skin diseases; pharmaceuticals and natural remedies for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; pharmaceutical compositions for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; chemico-pharmaceutical preparations for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; medicines for human purposes for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; medicinal healthcare preparations for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; medicinal preparations and substances for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; biotechnological preparations for medical use for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; stem cells for medical purposes; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for treating respiratory diseases; medicinal infusions for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; medicated compresses; preparations for detecting genetic predispositions for medical purposes; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the prevention of diseases of the cardio-vascular system; pharmaceutical preparations for the treatment of diseases of the musculo-skeletal system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical products for the treatment of viral diseases; pharmaceutical preparations for the prevention of inflammatory diseases; pharmaceutical preparations for the treatment of disorders caused by bacteria; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of disorders of the endocrine system; pharmaceutical preparations for ophthalmological use; pharmaceutical products for ophthalmological use; medicated plasters; transdermal patches for the treatment of diseases of the musculo-skeletal system; transdermal patches for medical treatment of the musculo-skeletal system diseases; liquid vitamin supplements; nutritional supplements; nutraceutical preparations for therapeutic or medical purposes for the treatment cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; nutraceuticals for use as a dietary supplement; vitamin preparations in the nature of food supplements; dietary supplements consisting of vitamins; nutraceuticals for therapeutic purposes for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; enzyme dietary supplements; vitamin and mineral supplements; disinfectants and antiseptics; viral vaccines

35 Promotional and advertising services; advertising services relating to pharmaceutical products; advertising services to promote public awareness of medical issues; advertising services to promote public awareness of medical conditions; advertising services relating to cosmetics; providing consumer product information relating to cosmetics; retail store services in relation to dietetic preparations; retail store services in relation to pharmaceutical preparations; online retail store services in relation to cosmetics; retail store services in relation to medical instruments; retail store services in relation to medical apparatus; retail store services for a pharmaceutical, veterinary and sanitary preparations and medical supplies

10 medical apparatus and instruments for treating cardiovascular disease, for treating osteoarthritis, for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; apparatus for administering pharmaceuticals, namely, medical devices for accessing subcutaneous structures of the human body; apparatus for administering drugs by inhalation sold empty; medical ventilators; oxygen inhalators for therapeutic purposes sold empty; infusion pumps to deliver medication; respiratory therapy instruments, namely, sterile disposable oxygen humidifiers and nebulizers for respiratory therapy sold pre-filled with water; medical apparatus for assisting breathing, namely, portable devices used for breathing exercises and for respiratory muscle training; portable nebulisers for medical purposes; ventilator breathing apparatus for artificial respiration; medical apparatus for the treatment of respiratory conditions, namely, infusion and injection devices for delivering pharmaceuticals and solutions, oxygen inhalators, infusion pumps, portable nebulisers for medical purposes, all sold emptymedical apparatus for the treatment of respiratory conditions, namely, infusion and injection devices for delivering pharmaceuticals and solutions, oxygen inhalators, infusion pumps, portable nebulisers for medical purposes, all sold empty; respiratory masks for medical purposes; inhalers for medical use, sold empty; nebulizers for respiration therapy; respirators for artificial respiration for medical purposes; apparatus for the alleviation of breathing difficulties, namely, infusion and injection devices; masks and equipment for artificial respiration; oxygenators for medical use; medical apparatus for facilitating the inhalation of pharmaceutical preparations, sold empty; vaporizers for the treatment of upper respiratory conditions; oxygen inhalers for medical use sold empty; diagnostic, examination and monitoring equipment, namely, equipment for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; surgical ophthalmic instruments; massage apparatus; dummies for babies; catheters for medical use; apparatus for the regeneration of stem cells for medical purposes; implantable subcutaneous drug delivery devices; prosthetics, namely, ligaments and tissues for vascular use and artificial implant; artificial limbs; orthopedic articles, namely, devices used in orthopedic transplant and/or implant surgery; orthopedic joint implants made of artificial materials; sphygmotensiometers; equipment for diagnosis, examinations and monitoring, namely, equipment for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events

42 Scientific and technology services, namely, pharmaceutical drug development services; technological research services in the field of pharmaceutical research and development; scientific research in the field of pharmacy; scientific research relating to biology; scientific research relating to genetics; scientific research and industrial research in the field of pharmaceutical research and development; scientific research and analysis, namely, pharmaceutical research and development; scientific and technological services relating to pharmaceutical drug and nutritional supplements development; medical and pharmacological research services; providing scientific information in the field of medical disorders and their treatment; development of pharmaceutical preparations and medicines; research and development in the pharmaceutical and biotechnology fields; bacteriological research and analysis; biological research and analysis; chemical research and analysis services; clinical research, namely, conducting clinical trials for others; biological research, clinical research in the field of respiratory science and medicine and medical research; industrial analysis and research services in the field of pharmaceutical research; stem cell research; scientific services relating to the isolation and cultivation of human tissues and cells; research and development in the field of microorganisms and cells

The mark consists a hexagon shape consisting on the left side of a letter "C" in pantone cool gray 4 C and on the right side of the stylized representation of an anchor formed by a circle and a right pointing arrow in fuchsia pantone 227 C.
CHIESI
The color(s) gray: pantone cool gray 4 c and fuchsia: pantone 227 c is/are claimed as a feature of the mark.

Trademark Events

Nov 17, 2022

Final Disposition Notice Sent To Ib

Nov 16, 2022

Final Disposition Processed

Nov 2, 2022

Final Disposition Notice Created, To Be Sent To Ib

Aug 2, 2022

Notice Of Registration Confirmation Emailed

Aug 2, 2022

Registered-Principal Register

May 17, 2022

Official Gazette Publication Confirmation E-Mailed

May 17, 2022

Published For Opposition

May 16, 2022

Notification Processed By Ib

Apr 27, 2022

Notification Of Possible Opposition Sent To Ib

Apr 27, 2022

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Apr 27, 2022

Notification Of Notice Of Publication E-Mailed

Apr 14, 2022

Law Office Publication Review Completed

Apr 12, 2022

Assigned To Lie

Apr 11, 2022

Approved For Pub - Principal Register

Apr 11, 2022

Examiner's Amendment Entered

Apr 11, 2022

Notification Of Examiners Amendment E-Mailed

Apr 11, 2022

Examiners Amendment E-Mailed

Apr 11, 2022

Examiners Amendment -Written

Mar 17, 2022

Teas/Email Correspondence Entered

Mar 16, 2022

Correspondence Received In Law Office

Mar 16, 2022

Teas Response To Office Action Received

Jan 10, 2022

Refusal Processed By Ib

Dec 22, 2021

Non-Final Action Mailed - Refusal Sent To Ib

Dec 22, 2021

Refusal Processed By Mpu

Nov 19, 2021

Non-Final Action (Ib Refusal) Prepared For Review

Nov 18, 2021

Non-Final Action Written

Nov 17, 2021

Assigned To Examiner

Oct 23, 2021

Application Filing Receipt Mailed

Oct 19, 2021

New Application Office Supplied Data Entered In Tram

Oct 14, 2021

Sn Assigned For Sect 66a Appl From Ib